---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-029428"
form_type: "8-K"
ticker: "AVTX"
cik: "0001534120"
company_name: "Avalo Therapeutics, Inc."
filed_at: "2024-06-24T23:59:59+00:00"
generated_at: "2026-06-01T02:26:31.778120+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Avalo Therapeutics posts updated investor presentation; no specifics available

## Summary
- Company posted an updated corporate presentation on its website dated June 2024.
- Presentation content is largely forward-looking statements and standard disclaimers.
- No new clinical data, financial guidance, or material business developments disclosed.
- Ticker AVTX; presentation intended for investor meetings.

## SEC filing metadata
- accession: 0001628280-24-029428
- form_type: 8-K
- ticker: AVTX
- cik: 0001534120
- company_name: Avalo Therapeutics, Inc.
- filed_at: 2024-06-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534120/000162828024029428/0001628280-24-029428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534120/000162828024029428/avtx-20240624.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-029428
- JSON: https://secwatch.observer/filing/0001628280-24-029428.json
- Plain text: https://secwatch.observer/filing/0001628280-24-029428.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.